Advocating for a cure for HIV/AIDS for three decades
“There is something that drives me, and I guess it’s just that we’re not there yet. Until we will, I’ll keep on working.”
“There is something that drives me, and I guess it’s just that we’re not there yet. Until we will, I’ll keep on working.”
A member of the California stem cell program’s board of directors, and San Francisco County Supervisor Jeff Sheehy is a tall, broad-shouldered man, with more than a passing resemblance to a young John Wayne. He has a daughter, Michele, age eleven; her eyes just shine when she looks at her Dad. So what is the
“When I was diagnosed with HIV, there were no possible treatments. People were even dying from the medication, it was so toxic.”
Thanks to funding from Proposition 71, California’s $3 billion investment in stem cell research, and the state funding entity it created, the California Institute for Regenerative Medicine (CIRM), there are now 36 human clinical trials in various stages of progress, including a trial for HIV/AIDS. Condition: HIV/AIDS Accepting Applicants: No Status: Phases 1/2 trial in progress Description: Clinical
Here's how stem cell research at City of Hope, USC and Sangamo Biosciences is leading to groundbreaking advances in treating HIV/AIDS.
HIV/AIDS weakens the immune system. Stem cell approaches involve removing HIV+ patients’ blood-forming stem cells—which eventually become all the cells of the immune system—then modifying them to be resistant to or fight HIV. These blood-forming stem cells can then be transplanted back into the patient and hopefully reduce the risks associated with HIV.